Esperion Therapeutics, Inc. 4.00% Convertible Senior Subordinated Notes due 2025Exchange Agreement • October 25th, 2021 • Esperion Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 25th, 2021 Company Industry Jurisdiction